Semaglutide denied for missing prior authorization by Humana?

Humana's specific coverage criteria for semaglutide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Prior Authorization for Semaglutide

Prior authorization (PA) denials for semaglutide from Humana almost always mean one of two things: the PA request was never submitted before the prescription was dispensed, or a PA was submitted but did not include enough clinical information to satisfy Humana's review criteria. PA is a gatekeeping step — it is not a determination that you do not qualify for the drug, only that coverage requires a clinical review first.

## Why This Denial Is Appealable

If a PA was submitted and denied on clinical grounds, you have the right to a full appeal under ACA Section 2719 and ERISA Section 503. If the PA was never submitted, the immediate path is typically to have your prescriber submit one now, though if time-sensitive doses have already been missed, a retroactive appeal or expedited review may also be appropriate. The external-review window — a review by an Independent Review Organization with no financial tie to the plan — is generally available for roughly four months from the date of the adverse determination.

## The Appeal Process

1. Clarify the denial type — was the PA never submitted, or was it submitted and denied? The denial letter should clarify this. 2. Submit or resubmit the PA with complete documentation — many PA denials are reversed when the original submission lacked clinical detail. 3. File an internal appeal if the PA was denied on clinical grounds; confirm the deadline on your Explanation of Benefits. 4. Request expedited review if you have an urgent medical need; decisions are generally required within 72 hours on the expedited track. 5. Escalate to external review if the internal appeal is denied.

## Documentation to Gather

• Diagnosis confirmation: recent chart notes, lab results, or clinical assessments establishing the underlying condition.
• Prior-treatment history: a chronological list of prior therapies, with dates started, dates stopped, and documented reasons for discontinuation or failure.
• Clinical severity documentation: objective findings from the medical record that support the medical necessity of initiating this therapy now.
• Prescriber PA letter: a detailed letter specifically addressing each criterion in Humana's PA requirements for this drug class — obtained from Humana's provider portal or coverage policy.

## Criteria-Mapping Structure

Download Humana's current PA criteria for semaglutide from their provider or member portal. List each criterion. For each one, provide the exact chart entry — date, provider, finding — that satisfies it. Submit this mapping alongside the prescriber's letter. A structured, criterion-by-criterion response converts a vague appeal narrative into a reviewable document that reduces discretionary denial.